BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32500397)

  • 1. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
    Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
    Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy.
    Dieli-Conwright CM; Wong L; Waliany S; Bernstein L; Salehian B; Mortimer JE
    Cancer; 2016 Sep; 122(17):2646-53. PubMed ID: 27219902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
    Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
    Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.
    Kabat GC; Kim MY; Lee JS; Ho GY; Going SB; Beebe-Dimmer J; Manson JE; Chlebowski RT; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1730-1735. PubMed ID: 28939589
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic syndrome and outcomes following early-stage breast cancer.
    Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
    Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
    Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
    Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
    Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic syndrome in postmenopausal breast cancer survivors].
    Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
    Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.
    Chen YH; Lee YC; Tsao YC; Lu MC; Chuang HH; Yeh WC; Tzeng IS; Chen JY
    BMJ Open; 2018 May; 8(5):e016554. PubMed ID: 29724734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
    Schmitt EB; Nahas-Neto J; Bueloni-Dias F; Poloni PF; Orsatti CL; Petri Nahas EA
    Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.
    Xia B; He Q; Pan Y; Gao F; Liu A; Tang Y; Chong C; Teoh AYB; Li F; He Y; Zhang C; Yuan J
    Int J Cancer; 2020 Dec; 147(12):3384-3393. PubMed ID: 32580250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
    You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
    Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Metabolic Syndrome on the Occurrence of Restenosis After Carotid Endarterectomy.
    Wallis de Vries BM; Timmerman N; van Laarhoven CJHCM; Visser L; Pol RA; El Moumni M; Pasterkamp G; de Borst GJ; Zeebregts CJ
    Eur J Vasc Endovasc Surg; 2019 Dec; 58(6):805-812. PubMed ID: 31653610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the prevalence of metabolic syndrome among overweight/obese African-American breast cancer survivors vs. matched non-cancer controls.
    Sheean P; Liang H; Schiffer L; Arroyo C; Stolley M
    J Cancer Surviv; 2017 Feb; 11(1):102-110. PubMed ID: 27562474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relation Between Metabolic Syndrome and Its Components with Breast Density in Postmenopausal Women.
    Kaya C; Cengiz H; Alay İ; Örs S; Kaya SE; Ekin M; Yaşar L
    Metab Syndr Relat Disord; 2019; 17(6):341-345. PubMed ID: 31045476
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
    Dibaba DT; Ogunsina K; Braithwaite D; Akinyemiju T
    Breast Cancer Res Treat; 2019 Feb; 174(1):209-218. PubMed ID: 30465158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort.
    Reeves KW; McLaughlin V; Fredman L; Ensrud K; Cauley JA
    Cancer Causes Control; 2012 Aug; 23(8):1241-51. PubMed ID: 22661101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number of Metabolic Syndrome Components Is the Central Predictor of the Impact of Metabolic Syndrome on Outcome of Percutaneous Nephrolithotomy in Staghorn Nephrolithiasis.
    Xu P; Wang J
    J Endourol; 2019 Nov; 33(11):946-953. PubMed ID: 31333070
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic syndrome and the risk of late onset Alzheimer's disease: An updated review and meta-analysis.
    Zuin M; Roncon L; Passaro A; Cervellati C; Zuliani G
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2244-2252. PubMed ID: 34039508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.